2 hrs ago
National Public Radio
FDA Expected To Approve New, Gentler Cure For Hepatitis C
The Food and Drug Administration is expected any day now to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer.
8 hrs ago
National Public Radio
FDA Set To Approve Hepatitis Drug
The Food and Drug Administration is expected soon to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer.
Wed Dec 04, 2013
9-year-old cancer survivor gives Christmas to other patients
The 9-year-old was a patient at Primary Children's Hospital last November, when he was diagnosed with his second bout of cancer - acute myeloid leukemia, caused by the chemotherapy he received for stage 4 liver cancer he had as a toddler.
BioAlliance Pharma: Approval to start ReLive (Livatag ) Phase III...
BioAlliance Pharma: Approval to start ReLive Phase III Clinical Trial in Primary Liver Cancer in the U.S. and Germany BioAlliance Pharma SA , an innovative Company dedicated to the development of orphan oncology and to supportive care products, announces that it has received authorization to start its Phase III ReLive clinical trial in primary ... (more)
Tue Dec 03, 2013
Liver stiffness can be used for risk stratification in chronic liver diseases
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases, reports the most recent issue of Clinical Gastroenterology & Hepatology.
Prayers Requested: ThreePuttinDude
"In late September/early October, he was diagnosed with metastatic liver cancer.
Mon Dec 02, 2013
Genomic Testing for HCV
Hepatitis C is finally gaining significant public awareness, thanks to the CDC and other organizations.
Sun Dec 01, 2013
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.
Hepatocellular carcinoma is a severe complication of advanced liver disease with a worldwide incidence of more than 600,000 patients per year.
Sat Nov 30, 2013
Targeting tyrosine kinase receptors in hepatocellular carcinoma.
The recent discoveries of genomic and molecular markers in hepatocellular carcinoma have improved the understanding about the complexity of the signal transduction pathways as well as their relevance in normal and liver cancer cells.
Fri Nov 29, 2013
Integrative molecular analysis of intrahepatic cholangiocarcinoma...
Cholangiocarcinoma, the second most common liver cancer, can be classified as intrahepatic cholangiocarcinoma or extrahepatic cholangiocarcinoma.
South Wales Argus
More hepatitis C cases linked to ex-Gwent health worker
TWO more women have been found to have contracted hepatitis C from a healthcare worker who had the disease without realising it, while working at a Gwent hospital.
Wed Nov 27, 2013
The Windsor Star
Cancer stricken family grateful for the help of friends
Amanda and Francis Ryall are overwhelmed with the kindness and generosity of friends and strangers who have helped them in their time of need.
Korean company seeks to buy cancer treatment developer Jennerex for up to $150 million
A South Korean contract research organization will buy San Francisco cancer immunotherapy developer Jennerex Biotherapeutics Inc. for up to $150 million, according to BioCentury .
The Health Benefits of Instant Coffee + You Are What You Drink?
Recent studies have reported numerous health benefits linked to coffee consumption.
Pentre Broughton woman in desperate plea for Welsh cancer help
A month later the 48-year-old had surgery to remove a large tumour from her bowel and lymph nodes, followed by six months of chemotherapy.
Tue Nov 26, 2013
Wall St. Cheat Sheet
Investors Should Avoid Celsion At All Costs
While dilution is a likely risk for investors dabbling in micro and small-cap biotech stocks, excessive dilution can be a real problem and result in large losses for early investors.
Global Liver Diseases Therapeutics Market Is Expected to Reach USD...
According to the latest market report published by Transparency Market Research "Liver Diseases Therapeutics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018", the global liver diseases therapeutics market was worth USD 6.5 billion in 2011 and is expected to reach USD 10.9 billion in 2018, growing at a CAGR of 8.6% ... (more)
SillaJen Announces Agreement to Acquire Jennerex, Inc.
Following the acquisition, Jennerex will become a wholly-owned subsidiary of SillaJen, but will keep its name and remain headquartered in .
Cambridge Evening News
Axed NHS liver cancer treatment that extends lives returns to Addenbrooke's
A Cambridge hospital has become one of only 10 NHS sites in England to offer a life-extending liver cancer treatment to patients.
Alcohol, addictive psychoactive drug
ALL ALCOHOLIC beverages contain the same chemical substance ethyl alcohol that has been consumed by mankind since prehistoric times.